Exact Mass: 560.3461

Exact Mass Matches: 560.3461

Found 500 metabolites which its exact mass value is equals to given mass value 560.3461, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dihydrocucurbitacin B

[(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate

C32H48O8 (560.3349)

23,24-dihydrocucurbitacin B is a 23,24-dihydrocucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at position 5; a hydroxy function at C-25 is acetylated. It is a 23,24-dihydrocucurbitacin, a secondary alpha-hydroxy ketone and a tertiary alpha-hydroxy ketone. It is functionally related to a cucurbitacin B. Dihydrocucurbitacin B is a natural product found in Bryonia alba, Citrullus colocynthis, and other organisms with data available. Dihydrocucurbitacin B, a triterpene isolated from Cayaponia tayuya roots, inhibits nuclear factor of activated T cells (NFAT), induces cell cycle arrested in the G0 phase, and inhibits delayed type hypersensitivity[1]. Dihydrocucurbitacin B, a triterpene isolated from Cayaponia tayuya roots, inhibits nuclear factor of activated T cells (NFAT), induces cell cycle arrested in the G0 phase, and inhibits delayed type hypersensitivity[1].

Deferoxamine

N-(5-aminopentyl)-N-hydroxy-N-[5-(N-hydroxy-3-{[5-(N-hydroxyacetamido)pentyl]carbamoyl}propanamido)pentyl]butanediamide

C25H48N6O8 (560.3533)

Deferoxamine is only found in individuals that have used or taken this drug. It is a natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. [PubChem]Deferoxamine works in treating iron toxicity by binding trivalent (ferric) iron (for which it has a strong affinity), forming ferrioxamine, a stable complex which is eliminated via the kidneys. 100 mg of deferoxamine is capable of binding approximately 8.5 mg of trivalent (ferric) iron. Deferoxamine works in treating aluminum toxicity by binding to tissue-bound aluminum to form aluminoxamine, a stable, water-soluble complex. The formation of aluminoxamine increases blood concentrations of aluminum, resulting in an increased concentration gradient between the blood and dialysate, boosting the removal of aluminum during dialysis. 100 mg of deferoxamine is capable of binding approximately 4.1 mg of aluminum. V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AC - Iron chelating agents D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].

Cucurbitacin C

(3E)-6-[5,13-Dihydroxy-1-(hydroxymethyl)-6,6,11,15-tetramethyl-17-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-14-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetic acid

C32H48O8 (560.3349)

Cucurbitacin C is found in cucumber. Cucurbitacin C is a constituent of Cucurbitaceae, e.g. Cucumis sativus (cucumber) Constituent of Cucurbitaceae, e.g. Cucumis sativus (cucumber). Cucurbitacin C is found in cucumber and fruits.

Cucurbitacin Q

C32H48O8 (560.3349)

Montanin

NSC-282158

C32H48O8 (560.3349)

3-Hydroxy-2,3-didehydro-beta,chi-caroten-4-one

C40H48O2 (560.3654)

Oleoyl danshenxinkun A

C36H48O5 (560.3502)

A diterpenoid with a fatty acyl side chain isolated from Salvia miltiorrhiza and has been shown to inhibit platelet aggregation induced by arachidonic acid.

Calophynic acid

Inocalophyllin A

C35H44O6 (560.3138)

25-benzoyloxyfriedelane-3,21-dione

C37H52O4 (560.3865)

7alpha-acetoxy-21R?,23R?-epoxy-24S?,25-dihydroxy-21alpha-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|7alpha-acetoxy-21S?,23R?-epoxy-24S?,25-dihydroxy-21beta-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|brujavanone I|brujavanone J

14-hydroxyplagiochiline-A-15-yl 2E,4E-dodecadienoate

C31H44O9 (560.2985)

3-[rel-(2R,3R)-4-hydroxy-6-(3alpha-isopropenyl-2,2-dimethylcyclobutyl-beta-methyl)-2,3-dimethyl-6-(3-methylbut-2-enyl)-5,7-dioxo-3,5,6,7-tetrahydro-2H-chromen-8-yl]-3-phenylpropionic acid|brasiliensophyllic acid A

3-[rel-(2R,3R)-4-hydroxy-6-(3alpha-isopropenyl-2,2-dimethylcyclobutyl-beta-methyl)-2,3-dimethyl-6-(3-methylbut-2-enyl)-5,7-dioxo-3,5,6,7-tetrahydro-2H-chromen-8-yl]-3-phenylpropionic acid|brasiliensophyllic acid A

C35H44O6 (560.3138)

Diosgenin-3-O-alpha-rhamnopyranosid

C33H52O7 (560.3713)

3alpha,22alpha-diacetoxy-20beta,21alpha,29-trihydrohy-30-norolean-12-ene

C33H52O7 (560.3713)

15(S)-HETE-biotin

15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraene-(2-biotinyl)hydrazide

C30H48N4O4S (560.3396)

Ser Asn Thr Ile Leu

C24H44N6O9 (560.317)

Ser Lys Cys Pro Leu

C24H44N6O7S (560.2992)

brassinolide 22-O-sulfate

C28H48O9S (560.3019)

Coumaroyl tomatidine

C37H52O4 (560.3865)

Cucurbitacin Q1

[(E,6R)-6-hydroxy-2-methyl-5-oxo-6-[(2S,3S,8S,9R,10R,13R,14S,16R,17R)-2,3,16-trihydroxy-4,4,9,13,14-pentamethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-3-en-2-yl] acetate

C32H48O8 (560.3349)

Cucurbitacin Q1 is a natural product found in Elaeocarpus chinensis and Hemsleya ellipsoidea with data available.

MLS002702118-01!Deferroxamine

C25H48N6O8 (560.3533)

deferoxamine

N-(5-aminopentyl)-N-hydroxy-N-[5-(N-hydroxy-3-{[5-(N-hydroxyacetamido)pentyl]carbamoyl}propanamido)pentyl]butanediamide

C25H48N6O8 (560.3533)

V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AC - Iron chelating agents D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].

NCGC00385539-01!

C32H48O8 (560.3349)

N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide

NCGC00178802-07!N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide

C25H48N6O8 (560.3533)

C32H48O8_Propanedioic acid, mono[12-(acetyloxy)-4,4,8,10,14-pentamethyl-17-(tetrahydro-2-methyl-5-oxo-2-furanyl)gonan-3-yl] ester

NCGC00385693-01_C32H48O8_Propanedioic acid, mono[12-(acetyloxy)-4,4,8,10,14-pentamethyl-17-(tetrahydro-2-methyl-5-oxo-2-furanyl)gonan-3-yl] ester

C32H48O8 (560.3349)

Desferrioxamine b

C25H48N6O8 (560.3533)

An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-glucosiduronate

C33H52O7 (560.3713)

C38H44N2O2 (560.3403)

TETRAETHYL 1,1-HEXAMETHYLENEBIS(2,5-DIMETHYL-1H-PYRROLE-3,4-DICARBOXYLATE)

C30H44N2O8 (560.3098)

DODECAETHYLENE GLYCOL MONOMETHYL ETHER

C25H52O13 (560.3408)

5-O-Benzylbazedoxifene

C37H40N2O3 (560.3039)

dodecane-1-thiol,2-methylidenebutanoic acid,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid,prop-2-enoic acid

C29H52O8S (560.3383)

7-Demethoxyegonol Oleate

C36H48O5 (560.3502)

A fatty acid ester that is egonol oleate in which the methoxy group at position 7 is replaced by a hydrogen. Isolated from the fruits of Styrax agrestis, it exhibits inhibitory activity against acetylcholinesterase.

Bothermon

C37H52O4 (560.3865)

13201-14-4

acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hexyl] ester

C32H48O8 (560.3349)

Dihydrocucurbitacin B, a triterpene isolated from Cayaponia tayuya roots, inhibits nuclear factor of activated T cells (NFAT), induces cell cycle arrested in the G0 phase, and inhibits delayed type hypersensitivity[1]. Dihydrocucurbitacin B, a triterpene isolated from Cayaponia tayuya roots, inhibits nuclear factor of activated T cells (NFAT), induces cell cycle arrested in the G0 phase, and inhibits delayed type hypersensitivity[1].

Cucurbitacin C

[(E)-6-[3,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

C32H48O8 (560.3349)

[(6R)-6-[(2S,9R,10R,13R,14S,16R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate

C32H48O8 (560.3349)

[(2S,3R,4R,5S)-2-[(2R,4R,5S,7S,12S,16S)-4,5-dihydroxy-2,16-dimethyl-8-oxo-9-oxatetracyclo[9.7.0.02,7.012,16]octadecan-15-yl]-4-hydroxy-5,6-dimethylheptan-3-yl] hydrogen sulfate

C28H48O9S (560.3019)

Cholcalciferyl-β-D-glucopyranosid-uronsaeure

6-[(3Z)-3-[(2E)-2-[7a-methyl-1-(6-methylheptan-2-yl)-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C33H52O7 (560.3713)

ST 28:1;O6;S

C28H48O9S (560.3019)

ST 29:0;O5;S

C29H52O8S (560.3383)

(15s,16r,19r)-15-ethyl-16-[(1r,9r,12r,19r)-12-ethyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-4-yl]-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene

C32H48O8 (560.3349)

{"Ingredient_id": "HBIN006940","Ingredient_name": "3,16,20,25-tetrahydroxycucurbita-5,23-diene-2,11,22-trione; (3\u03b2,16\u03b1,20r)-form,23,24-dihydro,25-ac","Alias": "NA","Ingredient_formula": "C32H48O8","Ingredient_Smile": "NA","Ingredient_weight": "560.72","OB_score": "NA","CAS_id": "121283-86-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8447","PubChem_id": "NA","DrugBank_id": "NA"}

(4aS,6aR,6bR,8aR,9R,10S,12aS,13R,14aS,14bS)-10-acetoxy-13-hydroxy-2,2,6b,9,12a,14a-hexamethyl-9-methylol-1,3,4,5,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-4a-carboxylic acid

(4aS,6aR,6bR,8aR,9R,10S,12aS,13R,14aS,14bS)-10-acetyloxy-13-hydroxy-9-(hydroxymethyl)-2,2,6b,9,12a,14a-hexamethyl-1,3,4,5,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-4a-carboxylic acid; (4aS,6aR,6bR,8aR,9R,10S,12aS,13R,14aS,14bS)-10-acetoxy-13-hydroxy-9-(hydroxymethyl)-2,2,6b,9,12a,14a-hexamethyl-1,3,4,5,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-4a-carboxylic acid

C32H48O8 (560.3349)

{"Ingredient_id": "HBIN010244","Ingredient_name": "(4aS,6aR,6bR,8aR,9R,10S,12aS,13R,14aS,14bS)-10-acetoxy-13-hydroxy-2,2,6b,9,12a,14a-hexamethyl-9-methylol-1,3,4,5,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-4a-carboxylic acid","Alias": "(4aS,6aR,6bR,8aR,9R,10S,12aS,13R,14aS,14bS)-10-acetyloxy-13-hydroxy-9-(hydroxymethyl)-2,2,6b,9,12a,14a-hexamethyl-1,3,4,5,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-4a-carboxylic acid; (4aS,6aR,6bR,8aR,9R,10S,12aS,13R,14aS,14bS)-10-acetoxy-13-hydroxy-9-(hydroxymethyl)-2,2,6b,9,12a,14a-hexamethyl-1,3,4,5,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydropicene-4a-carboxylic acid","Ingredient_formula": "C32H48O8","Ingredient_Smile": "NA","Ingredient_weight": "560.72","OB_score": "17.83815774","CAS_id": "130756-02-4","SymMap_id": "SMIT05853","TCMID_id": "NA","TCMSP_id": "MOL003838","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

acinospesigenin

C32H48O8 (560.3349)

{"Ingredient_id": "HBIN014555","Ingredient_name": "acinospesigenin","Alias": "NA","Ingredient_formula": "C32H48O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14169","TCMID_id": "545","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,2r,6r,10r,11s,13s,14r,15r)-14-(acetyloxy)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl decanoate

C32H48O8 (560.3349)

[(1s,2r,5r,6s,7r,9r,11s,12s,15r,16r)-6-hydroxy-15-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-5-methoxy-2-methyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-16-yl]methyl acetate

(1s,2s,3s,4as,4br,6as,7s,10as,10br,12s,12as)-2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl (3r)-3-hydroxybutanoate

C33H52O7 (560.3713)

3-[(2r,3s)-6-{[(1s,3s)-2,2-dimethyl-3-(prop-1-en-2-yl)cyclobutyl]methyl}-7-hydroxy-2,3-dimethyl-6-(3-methylbut-2-en-1-yl)-4,5-dioxo-2,3-dihydro-1-benzopyran-8-yl]-3-phenylpropanoic acid

C35H44O6 (560.3138)

3-[2-(2h-1,3-benzodioxol-5-yl)-1-benzofuran-5-yl]propyl octadec-9-enoate

C36H48O5 (560.3502)

methyl (1r,2s,4ar,4bs,6as,9r,10r,10as,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

methyl (1r,2s,4ar,4bs,6as,9r,10r,10as,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

C33H52O7 (560.3713)

3-(6-{[2,2-dimethyl-3-(prop-1-en-2-yl)cyclobutyl]methyl}-4-hydroxy-2,3-dimethyl-6-(3-methylbut-2-en-1-yl)-5,7-dioxo-2,3-dihydro-1-benzopyran-8-yl)-3-phenylpropanoic acid

C35H44O6 (560.3138)

(2s)-2-[bis(3-methylbut-2-en-1-yl)amino]-n-[(2s)-1-[(2s)-2-[4-(methoxycarbonyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-3-methylpentanimidic acid

C30H48N4O4S (560.3396)

7-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C31H44O9 (560.2985)

methyl (2z)-7,10-dihydroxy-2-(1-methoxy-1-oxopropan-2-ylidene)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydrochrysene-6a-carboxylate

C32H48O8 (560.3349)

2-(1-hydroxy-8-methyl-3,4-dioxophenanthren-2-yl)propyl (9z)-octadec-9-enoate

C36H48O5 (560.3502)

(1r,2r,4s,8r,10r,14s,17s,18r)-14-hydroxy-17-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one

(1r,2r,4s,8r,10r,14s,17s,18r)-14-hydroxy-17-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one

C33H52O7 (560.3713)

methyl (2r,6s)-6-[(1s,3s,3ar,5ar,9as,11s,11ar)-3,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-4,7,10-trioxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-4-oxoheptanoate

C31H44O9 (560.2985)

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-4-(acetyloxy)-9-hydroxy-3,6,6,10,14-pentamethyl-13-[(2-methylpropanoyl)oxy]-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl (2e)-2-methylbut-2-enoate

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-4-(acetyloxy)-9-hydroxy-3,6,6,10,14-pentamethyl-13-[(2-methylpropanoyl)oxy]-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl (2e)-2-methylbut-2-enoate

C31H44O9 (560.2985)

3-[(5-aminopentyl)(hydroxy)carbamoyl]-n-[5-(n-hydroxy-3-{[5-(n-hydroxyacetamido)pentyl]-c-hydroxycarbonimidoyl}propanamido)pentyl]propanimidic acid

C25H48N6O8 (560.3533)

(3r)-3-[(2r,3s,6s)-6-{[(1s,3s)-2,2-dimethyl-3-(prop-1-en-2-yl)cyclobutyl]methyl}-5-hydroxy-2,3-dimethyl-6-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]-3-phenylpropanoic acid

C35H44O6 (560.3138)

(1s,3r,7r,10s,13s,14r,15s)-1-hydroxy-17-[(1s,2s)-1-hydroxy-1-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]propan-2-yl]-9,9,14-trimethyl-5-oxo-4,8-dioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁴,¹⁸]icos-17-en-15-yl acetate

(1s,3r,7r,10s,13s,14r,15s)-1-hydroxy-17-[(1s,2s)-1-hydroxy-1-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]propan-2-yl]-9,9,14-trimethyl-5-oxo-4,8-dioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁴,¹⁸]icos-17-en-15-yl acetate

C31H44O9 (560.2985)

6-{2,7-dihydroxy-3a,6,6,9b,11a-pentamethyl-8,10-dioxo-1h,2h,3h,3bh,4h,7h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-2-methyl-5-oxoheptan-2-yl acetate

C32H48O8 (560.3349)

(1r,3s,5s,6ar,7s,8s,10r,10as)-1,3,10-tris(acetyloxy)-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (2r)-2-methylbutanoate

C31H44O9 (560.2985)

5-{3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-5-(acetyloxy)-2-hydroxy-2,3,4-trimethylpentyl acetate

C33H52O7 (560.3713)

2-hydroxy-3-{[3-(n-hydroxydodecanamido)propyl]-c-hydroxycarbonimidoyl}-2-({[3-(n-hydroxyacetamido)propyl]-c-hydroxycarbonimidoyl}methyl)propanoic acid

C26H48N4O9 (560.3421)

2-[(2-{[2-({2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-1-hydroxypropylidene}amino)-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene)amino]-4-(methylsulfanyl)butanoic acid

2-[(2-{[2-({2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-1-hydroxypropylidene}amino)-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene)amino]-4-(methylsulfanyl)butanoic acid

C24H44N6O7S (560.2992)

10,11-dihydroxy-4a,9-bis(methoxycarbonyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid

C32H48O8 (560.3349)

n-[(1s,3r,4s,6r,7s,8r,16s,17s,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,12-dien-16-yl]benzenecarboximidic acid

n-[(1s,3r,4s,6r,7s,8r,16s,17s,20r)-6-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icosa-10,12-dien-16-yl]benzenecarboximidic acid

C35H48N2O4 (560.3614)

(1r,2r,6s,7s,8r,10s,11s,12r,14r,16r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-16-(prop-1-en-2-yl)-14-undecyl-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-5-one

(1r,2r,6s,7s,8r,10s,11s,12r,14r,16r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-16-(prop-1-en-2-yl)-14-undecyl-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-5-one

C32H48O8 (560.3349)

methyl (1s,2s,4as,4br,6as,9r,10r,10ar,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate

(2s,3r,4s,5s)-2-[(1's,2r,2's,4's,7's,8'r,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxane-3,4,5-triol

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11r,11ar)-11-(acetyloxy)-3a,3b,6,6,9a-pentamethyl-1-[(2s)-2-methyl-5-oxooxolan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C32H48O8 (560.3349)

n-[(1s,6r,7s,8r,10s,11r,14s,15s,16s)-8-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-6,10,15-trimethyl-19-oxapentacyclo[13.3.2.0¹,¹⁴.0³,¹¹.0⁶,¹⁰]icosa-3,17-dien-16-yl]benzenecarboximidic acid

n-[(1s,6r,7s,8r,10s,11r,14s,15s,16s)-8-(acetyloxy)-7-[(1s)-1-(dimethylamino)ethyl]-6,10,15-trimethyl-19-oxapentacyclo[13.3.2.0¹,¹⁴.0³,¹¹.0⁶,¹⁰]icosa-3,17-dien-16-yl]benzenecarboximidic acid

C35H48N2O4 (560.3614)

5-(acetyloxy)-5-{2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate

C33H52O7 (560.3713)

9-(acetyloxy)-10,11-dihydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate

C33H52O7 (560.3713)

(3r)-3-[(2r,3s,6s)-6-{[(1s,3s)-2,2-dimethyl-3-(prop-1-en-2-yl)cyclobutyl]methyl}-4-hydroxy-2,3-dimethyl-6-(3-methylbut-2-en-1-yl)-5,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]-3-phenylpropanoic acid

C35H44O6 (560.3138)

(1r,3r,5s,6ar,7r,8s,10s,10ar)-1,3-bis(acetyloxy)-10-hydroxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl octanoate

C32H48O8 (560.3349)

6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-16-(prop-1-en-2-yl)-14-undecyl-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-5-one

C32H48O8 (560.3349)

2-(3-hydroxy-8-methyl-1,4-dioxophenanthren-2-yl)propyl octadec-9-enoate

C36H48O5 (560.3502)

(1s,4r,5r,8r,10s,13r,14r,16r,17s,18s,19s,20r)-4,5,9,9,13,19,20-heptamethyl-23-oxo-24-oxahexacyclo[14.6.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl benzoate

C37H52O4 (560.3865)

(3r)-3-[(2s,3s,6s)-6-{[(1s,3s)-2,2-dimethyl-3-(prop-1-en-2-yl)cyclobutyl]methyl}-5-hydroxy-2,3-dimethyl-6-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]-3-phenylpropanoic acid

C35H44O6 (560.3138)

n-[(1s,2r,5r,6s,8r,9s,10r,17r,20r)-8-(acetyloxy)-9-[(1s)-1-(dimethylamino)ethyl]-1,6,10-trimethyl-18-oxapentacyclo[15.2.1.0²,¹⁵.0⁵,¹³.0⁶,¹⁰]icosa-12,15-dien-20-yl]benzenecarboximidic acid

n-[(1s,2r,5r,6s,8r,9s,10r,17r,20r)-8-(acetyloxy)-9-[(1s)-1-(dimethylamino)ethyl]-1,6,10-trimethyl-18-oxapentacyclo[15.2.1.0²,¹⁵.0⁵,¹³.0⁶,¹⁰]icosa-12,15-dien-20-yl]benzenecarboximidic acid

C35H48N2O4 (560.3614)

(1r,2r,6s,7s,8r,10s,11s,12r,14s,16r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-16-(prop-1-en-2-yl)-14-undecyl-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-5-one

(1r,2r,6s,7s,8r,10s,11s,12r,14s,16r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-16-(prop-1-en-2-yl)-14-undecyl-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-5-one

C32H48O8 (560.3349)

4-formylphenyl 10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C37H52O4 (560.3865)

6-hydroxy-2-methyl-5-oxo-6-{2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-10-oxo-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl}hept-3-en-2-yl acetate

C32H48O8 (560.3349)

(2s,3r,4s,5r,6r)-2-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13's,14'r,16's)-16'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-14'-yl]-6-methyloxane-3,4,5-triol

(2s,3r,4s,5r,6r)-2-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13's,14'r,16's)-16'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-14'-yl]-6-methyloxane-3,4,5-triol

C33H52O7 (560.3713)

(1s,2s,4s,5r,8s,10r,11s,14r,15r,18s)-5-hydroxy-10,14-dimethyl-9-oxo-15-[(1s)-1-[(1r,3r,5s)-1,5,6,6-tetramethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-8-yl acetate

(1s,2s,4s,5r,8s,10r,11s,14r,15r,18s)-5-hydroxy-10,14-dimethyl-9-oxo-15-[(1s)-1-[(1r,3r,5s)-1,5,6,6-tetramethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-8-yl acetate

C32H48O8 (560.3349)

(2s,3r,4r,4ar,6as,6br,8ar,10r,12ar,12br,14br)-10-(acetyloxy)-3-hydroxy-2-(hydroxymethyl)-2-methoxy-6a,6b,9,9,12a-pentamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picen-4-yl acetate

C33H52O7 (560.3713)

(2s)-2-{[(2s)-2-{[(2s,3s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-1-hydroxypropylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene]amino}-4-(methylsulfanyl)butanoic acid

(2s)-2-{[(2s)-2-{[(2s,3s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-1-hydroxypropylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene]amino}-4-(methylsulfanyl)butanoic acid

C24H44N6O7S (560.2992)

6-{2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-2-methyl-5-oxoheptan-2-yl acetate

C32H48O8 (560.3349)

(1s,3r,5r,6as,7r,8r,10s,10as)-1,3-bis(acetyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl octanoate

C32H48O8 (560.3349)

{[(4z,6z,10z)-3,20,22-trihydroxy-13,14,17-trimethoxy-4,8,10,12,16-pentamethyl-2-azabicyclo[16.3.1]docosa-1(22),2,4,6,10,18,20-heptaen-9-yl]oxy}methanimidic acid

C30H44N2O8 (560.3098)

(2r,3r,4s,5s)-2-[(1's,2r,2's,4's,7's,8'r,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-14'-oloxy]oxane-3,4,5-triol

(2r,3r,4s,5s)-2-[(1's,2r,2's,4's,7's,8'r,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-14'-oloxy]oxane-3,4,5-triol

C32H48O8 (560.3349)

(1r,3s,3as,3br,7s,9ar,9bs,11as)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one

(1r,3s,3as,3br,7s,9ar,9bs,11as)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one

C33H52O7 (560.3713)

1,3-bis(acetyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl octanoate

C32H48O8 (560.3349)

(1s)-1-[(1s,3r)-3-{2-[(1s,2s,4s,5's)-4-hydroxy-1,5,5-trimethyl-3,6-dioxaspiro[bicyclo[2.2.2]octane-2,2'-oxan]-5'-yl]ethyl}-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H48O8 (560.3349)

(4ar,5s,8r,8ar)-8a-hydroxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-8-yl (2r,3s,4e)-6-[(acetyloxy)methyl]-3-hydroxy-2,4-dimethyldodec-4-enoate

C32H48O8 (560.3349)